Zambia and China Finalize Vaccine Manufacturing Agreement

Zambia and a Chinese firm have finalized a joint venture agreement to establish a vaccine manufacturing facility. The project, named ZAMVAX Limited, is set to be developed through a US$200 million partnership between the Industrial Development Corporation (IDC) and Jijia (Beijing) International Medical Technology Limited.

The agreement outlines a two-phase project, with the first phase focusing on setting up an oral cholera vaccine fill-and-finish facility. The facility is expected to have a production capacity of up to 20 million doses annually.

Under the joint venture, the Industrial Development Corporation will hold a 60-per cent shareholding, while Jijia (Beijing) International Medical Technology Limited will own 40 per cent of the company.